Literature DB >> 25750292

Aberrant methylation of GCNT2 is tightly related to lymph node metastasis of primary CRC.

Kazunori Nakamura1, Keishi Yamashita1, Hiromichi Sawaki2, Mina Waraya1, Hiroshi Katoh1, Nobukazu Nakayama1, Hiroshi Kawamata1, Hiroshi Nishimiya1, Akira Ema1, Hisashi Narimatsu2, Masahiko Watanabe3.   

Abstract

BACKGROUND: Glycoprotein expression profile is dramatically altered in human cancers; however, specific glycogenes have not been fully identified.
MATERIALS AND METHODS: A comprehensive real-time polymerase chain reaction (PCR) system for glycogenes (CRPS-G) identified several outstanding glycogenes. GCNT2 was of particular interest after GCNT2 expression and epigenetics were rigorously investigated in primary colorectal cancer (CRC).
RESULTS: The highlights of this work can be summarized as follows: (i) Expression of GCNT2 was remarkably suppressed. (ii) Silenced expression of GCNT2 was reactivated by combined demethylating agents. (iii) Promoter DNA methylation of GCNT2 was silenced in CRC cell lines and tissues. Hypomethylation of GCNT2 variant 2 is tightly associated with lymph node metastasis in primary CRC. (iv) GCNT2 methylation level in the normal tissues also showed a close association with that in the tumor tissues and reflected lymph node metastasis.
CONCLUSION: We identified aberrant expression of GCNT2, which can be explained by promoter DNA hypermethylation. Hypomethylation of the GCNT2 variant 2 reflected lymph node metastasis of CRC in the tumor and normal tissues. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  GCNT2; colorectal cancer; epigenetics; glycogene; lymph node metastasis

Mesh:

Substances:

Year:  2015        PMID: 25750292

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  I-branched carbohydrates as emerging effectors of malignant progression.

Authors:  Charles J Dimitroff
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-18       Impact factor: 11.205

2.  Study of the Relationship Between Serum Amino Acid Metabolism and Lymph Node Metastasis in Patients with Colorectal Cancer.

Authors:  Jinhao Liu; Jikun Wang; Xueqian Ma; Yang Feng; Yanlei Chen; Yanping Wang; Dong Xue; Shifeng Qiao
Journal:  Onco Targets Ther       Date:  2020-10-13       Impact factor: 4.147

3.  GCNT4 is Associated with Prognosis and Suppress Cell Proliferation in Gastric Cancer.

Authors:  Hui Sun; Jinjia Chang; Min Ye; Weiwei Weng; Meng Zhang; Shujuan Ni; Cong Tan; Dan Huang; Lei Wang; Xiang Du; Mi-Die Xu; Weiqi Sheng
Journal:  Onco Targets Ther       Date:  2020-08-25       Impact factor: 4.147

Review 4.  Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target.

Authors:  M Perez; A Chakraborty; L S Lau; N B B Mohammed; C J Dimitroff
Journal:  Br J Dermatol       Date:  2021-05-04       Impact factor: 11.113

5.  Network analysis based on TCGA reveals hub genes in colon cancer.

Authors:  Fenzan Wu; Guoping Yuan; Junjie Chen; Chengzu Wang
Journal:  Contemp Oncol (Pozn)       Date:  2017-06-30

Review 6.  Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers.

Authors:  Marco Trinchera; Adele Aronica; Fabio Dall'Olio
Journal:  Biology (Basel)       Date:  2017-02-23

7.  A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis.

Authors:  Rohitesh Gupta; Frank Leon; Sanchita Rauth; Surinder K Batra; Moorthy P Ponnusamy
Journal:  Cells       Date:  2020-02-14       Impact factor: 6.600

8.  Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal cancer.

Authors:  Jun Ma; Peilong Wang; Lei Huang; Jianxia Qiao; Jianhong Li
Journal:  BMC Med Genomics       Date:  2021-02-27       Impact factor: 3.063

9.  Epithelial-Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma.

Authors:  Constantin Busuioc; Cristina Alexandra Ciocan-Cartita; Cornelia Braicu; Oana Zanoaga; Lajos Raduly; Monica Trif; Mihai-Stefan Muresan; Calin Ionescu; Cristina Stefan; Carmen Crivii; Nadim Al Hajjar; Simona Mǎrgǎrit; Ioana Berindan-Neagoe
Journal:  J Pers Med       Date:  2021-05-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.